SpectraCure AB (publ) (FRA:2OK)

Germany flag Germany · Delayed Price · Currency is EUR
0.0024
-0.0006 (-20.00%)
At close: Jan 9, 2026
-98.75%
Market Cap4.63M
Revenue (ttm)n/a
Net Income (ttm)-4.81M
Shares Outn/a
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0024
Previous Close0.0030
Day's Range0.0024 - 0.0024
52-Week Range0.0001 - 0.2530
Betan/a
RSI33.68
Earnings DateFeb 20, 2026

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 16
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2OK
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.